Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,293 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts.
Sharpe BP, Hayden A, Manousopoulou A, Cowie A, Walker RC, Harrington J, Izadi F, Breininger SP, Gibson J, Pickering O, Jaynes E, Kyle E, Saunders JH, Parsons SL, Ritchie AA, Clarke PA, Collier P, Mongan NP, Bates DO, Yacqub-Usman K, Garbis SD, Walters Z, Rose-Zerilli M, Grabowska AM, Underwood TJ. Sharpe BP, et al. Among authors: harrington j. Cell Rep Med. 2022 Jun 21;3(6):100541. doi: 10.1016/j.xcrm.2022.100541. Cell Rep Med. 2022. PMID: 35732148 Free PMC article.
Pathogenic KDM5B variants in the context of developmental disorders.
Harrington J, Wheway G, Willaime-Morawek S, Gibson J, Walters ZS. Harrington J, et al. Biochim Biophys Acta Gene Regul Mech. 2022 Jul;1865(5):194848. doi: 10.1016/j.bbagrm.2022.194848. Epub 2022 Jul 26. Biochim Biophys Acta Gene Regul Mech. 2022. PMID: 35905858 Free article. Review.
Residual cancer cells after apparent complete pathological response to neoadjuvant therapy in oesophageal adenocarcinoma.
Walker RC, Harrington J, Breininger SP, Pickering O, Hill SL, Sharpe BP, Grace B, Reddin I, Rajak R, Manousopoulou A, Garbis SD, Walters ZS, Rose-Zerilli MJJ, Underwood TJ. Walker RC, et al. Among authors: harrington j. Br J Surg. 2024 Apr 3;111(4):znae103. doi: 10.1093/bjs/znae103. Br J Surg. 2024. PMID: 38630793 Free PMC article. No abstract available.
Patient-derived tumor organoid and fibroblast assembloid models for interrogation of the tumor microenvironment in esophageal adenocarcinoma.
Sharpe BP, Nazlamova LA, Tse C, Johnston DA, Thomas J, Blyth R, Pickering OJ, Grace B, Harrington J, Rajak R, Rose-Zerilli M, Walters ZS, Underwood TJ. Sharpe BP, et al. Among authors: harrington j. Cell Rep Methods. 2024 Dec 16;4(12):100909. doi: 10.1016/j.crmeth.2024.100909. Epub 2024 Nov 27. Cell Rep Methods. 2024. PMID: 39610249 Free article.
Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre-specified analysis of the EMPACT-MI trial.
Petrie MC, Udell JA, Anker SD, Harrington J, Jones WS, Mattheus M, Gasior T, van der Meer P, Amir O, Bahit MC, Bauersachs J, Bayes-Genis A, Chopra VK, Januzzi JL, Lopes RD, Ponikowski P, Rossello X, Schou M, Zieroth S, Brueckmann M, Sumin M, Bhatt DL, Hernandez AF, Butler J. Petrie MC, et al. Among authors: harrington j. Eur J Heart Fail. 2024 Dec 26. doi: 10.1002/ejhf.3548. Online ahead of print. Eur J Heart Fail. 2024. PMID: 39725521
1,293 results